Resmed (RMD) Gets a Hold from RBC Capital
RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.
RBC Capital Reaffirms Their Hold Rating on HUB24 Limited (FSB)
In a report released on January 29, Jack Lynch from RBC Capital maintained a Hold rating on HUB24 Limited (FSB – Research Report), with a price ...
Triton International Announces Pricing of Public Offering of Series F Preference Shares
Triton International Limited (the "Company" or "Triton") today announced the pricing of an underwritten offering of 6,000,000 ...
Higher capital requirements for UBS will raise costs for others, CEO says
Imposing higher capital requirements on UBS as a systemically relevant bank will usher in higher costs for companies and ...
Tesla is acting like an AI stock. Should investors focus more on auto trends?
That helps underscore UBS analyst Joseph Spak's belief that investors don't really view Tesla (TSLA) as a carmaker any more. "We can almost definitively say the market doesn't treat TSLA like an auto ...
fintechmagazine22h
How UBS Deploys Microsoft AI Platform in Global Operations
UBS implements Azure-based assistant to 30,000 staff in Asian and European booking centres through enterprise-scale ...
Wells Fargo lifts Meta Platforms price target to $752
Wells Fargo (NYSE:WFC) set a new price target for Meta Platforms Inc. (NASDAQ: NASDAQ:META) stock, increasing it to $752.00 from the previous $685.00, while maintaining an Overweight rating on the ...
Meta stock price target raised to $800 by Bernstein
Bernstein analysts increased the price target for Meta Platforms Inc. (NASDAQ: NASDAQ:META) shares, raising it to $800 from the previous $685, while maintaining an Outperform rating. With Meta trading ...